Clinical trial
Study to Determine the Clinical Significance of Intravascular OCT-NIRAF
NCT06374498 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Determine the Clinical Significance of Intravascular OCT-NIRAF
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- July 8, 2024
- Completion date
- April 30, 2028
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.